A detailed history of Vanguard Group Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,448,671 shares of FLGT stock, worth $25.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,448,671
Previous 1,435,425 0.92%
Holding current value
$25.9 Million
Previous $28.2 Million 11.72%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$19.6 - $25.06 $259,621 - $331,944
13,246 Added 0.92%
1,448,671 $31.5 Million
Q2 2024

Aug 13, 2024

BUY
$19.09 - $22.57 $209,550 - $247,750
10,977 Added 0.77%
1,435,425 $28.2 Million
Q1 2024

May 10, 2024

BUY
$21.55 - $29.29 $177,938 - $241,847
8,257 Added 0.58%
1,424,448 $30.9 Million
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $531,427 - $680,469
22,480 Added 1.61%
1,416,191 $40.9 Million
Q3 2023

Nov 14, 2023

BUY
$26.74 - $40.81 $83,936 - $128,102
3,139 Added 0.23%
1,393,711 $37.3 Million
Q2 2023

Aug 14, 2023

BUY
$28.52 - $40.7 $351,394 - $501,464
12,321 Added 0.89%
1,390,572 $51.5 Million
Q1 2023

May 15, 2023

SELL
$29.39 - $36.27 $457,984 - $565,195
-15,583 Reduced 1.12%
1,378,251 $43 Million
Q4 2022

Feb 10, 2023

BUY
$29.23 - $40.28 $821,304 - $1.13 Million
28,098 Added 2.06%
1,393,834 $41.5 Million
Q3 2022

Nov 14, 2022

BUY
$37.92 - $63.74 $1.22 Million - $2.05 Million
32,173 Added 2.41%
1,365,736 $52.1 Million
Q2 2022

Aug 12, 2022

SELL
$47.98 - $62.75 $278,667 - $364,452
-5,808 Reduced 0.43%
1,333,563 $72.7 Million
Q1 2022

May 13, 2022

BUY
$49.85 - $96.11 $1.33 Million - $2.57 Million
26,731 Added 2.04%
1,339,371 $83.6 Million
Q4 2021

Feb 14, 2022

BUY
$77.3 - $105.0 $379,233 - $515,130
4,906 Added 0.38%
1,312,640 $132 Million
Q3 2021

Nov 12, 2021

BUY
$74.87 - $110.87 $2.11 Million - $3.12 Million
28,175 Added 2.2%
1,307,734 $118 Million
Q2 2021

Aug 13, 2021

BUY
$66.8 - $100.45 $85.5 Million - $129 Million
1,279,559 New
1,279,559 $118 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $541M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.